Showing results (141-150 of 165) with videos related to
Sort By:
Pageof 17
Nature Communications|April 15, 2020
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomasJay Daniels, Peter G Doukas, Maria E Martinez Escala, et al.Blood Cancer Journal|August 1, 2025
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-upEva Domingo-Domènech, Barbara Pro, Tim Illidge, et al.Acta Haematologica|July 18, 2019
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE RegistryFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.Lancet (London, England)|December 8, 2018
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trialSteven Horwitz, Owen A O'Connor, Barbara Pro, et al.Blood|June 11, 2021
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneityJoonhee Park, Jay Daniels, Tim Wartewig, et al.Cancer|January 30, 2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort studySteven I Park, Steven M Horwitz, Francine M Foss, et al.Cancer|December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United StatesKenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelinesRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.Blood Neoplasia|October 23, 2025
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemiaEvelyn H Orlando, Patrick Gould, Brian Cuzzo, et al.Leukemia & Lymphoma|March 8, 2017
Report of the 6th International Workshop on PET in lymphomaCristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, et al.Pageof 17